• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 67 of 100
How a Biotech Turned a Bust Into a Hit
HealthHow a Biotech Turned a Bust Into a Hit
By Jennifer AlseverSeptember 26, 2016
How Time Warner’s Former CEO Is Helping Democratize Cancer Research
LeadershipHow Time Warner’s Former CEO Is Helping Democratize Cancer Research
By Sy MukherjeeSeptember 23, 2016
Attorney general Loretta Lynch said the department will issue a new plan next week.
Health35 US States Are Suing This Opioid Maker for Anticompetitive Practices
By ReutersSeptember 23, 2016
Herpes Treatment
HealthThis Acne Treatment Now Costs Almost $10,000
By Madeline FarberSeptember 21, 2016
Senate Republicans Want Probe of Mylan EpiPen Price Hikes and Rebates
HealthSenate Republicans Want Probe of Mylan EpiPen Price Hikes and Rebates
By ReutersSeptember 21, 2016
The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal
FinanceBayer Shares Rise After It Ups Sales Targets for Top-Selling Drugs
By ReutersSeptember 20, 2016
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
HealthNovartis Says MS Drug Cut Risk of Disability Advance in Study
By ReutersSeptember 17, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthA Minnesota Doctor Is Trying Get a $50 EpiPen Alternative to Market
By Sy MukherjeeSeptember 15, 2016
Meet the Federal Government’s Pot Dealer
HealthMeet the Federal Government’s Pot Dealer
By Andrew Joseph and STAT NewsSeptember 15, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
HealthMylan Reportedly Paid Its Executives More Than Bigger Rivals
By Tom Huddleston Jr.September 14, 2016
Mylan EpiPen; epinephrine injection, 0.3 mg
HealthThis Vote Could Finally Make a Difference in Crazy Drug Prices
By Sy MukherjeeSeptember 14, 2016
GERMANY-AGRICULTURE-BAYER-MONSANTO-MERGER
FinanceBayer, Monsanto Agree to Merge in $66 Billion Deal
By Reuters and Fortune EditorsSeptember 14, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthMylan Agrees to Hand Over EpiPen Documents to Congress
By Sy MukherjeeSeptember 13, 2016
General Economy Images In Bangladesh
HealthU.S. Justice Department Subpoenas Taro Over Generic Drug Pricing
By ReutersSeptember 11, 2016
CNBC Events
HealthAllergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices
By Sy MukherjeeSeptember 6, 2016
1...
  • 65
  • 66
  • 67
  • 68
  • 69
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.